3654 results for «370»
3654 results
Meaningful innovations in interventional cardiology
18 May 2023 – From EuroPCR 2023
In this session, watch the case of a 56-year-old man with HTN, DM, stable CAD, PFO and previous ischaemic stroke, who presented with severely calcified CTO lesion on proximal LAD and significant mid-RCA lesion, and find out how he was treated LIVE... among others!
Redo-TAVI and patient pathway optimisation - Lifetime management decisions today for challenges of the future!
18 May 2023 – From EuroPCR 2023
Watch this session if you want to learn more about the BENCHMARK Registry and its key findings, explore how patients can benefit from optimised TAVI programmes, get an idea of how challenging Redo-TAVI will be for everyday practice in the future, and to view a LIVE...
DCB and scaffolds
16 May 2023 – From EuroPCR 2023
Watch this session to learn about 4 cases, including a patient who underwent successful PTCA with BRS on LAD using the PSP technique, and discuss the best option to consider when choosing between DEB and stents in tricky situations and individual patients.
Contemporary best clinical practice for TAVI
18 May 2023 – From EuroPCR 2023
This interactive session is designed to show how a good pre-procedural assessment can facilitate the planning of a procedure. It also shows how a certain valve can be best suited for patients with certain phenotypes, and finally how to fully optimise the procedure to obtain the...
Complex vascular access for TAVI procedure
16 May 2023 – From EuroPCR 2023
“Application of peripheral endovascular technology in TAVI”, “TAVI with novel device, concomitant aortic aneurysm repair and outcomes”, “Path for glory is calcified and tortuous” are a few of the cases featured in this session. Tune in to gain a comprehensive insight into effective management strategies for...
Left main and complex bifurcation stenting
18 May 2023 – From EuroPCR 2023
Want more training on bifurcation stenting? Learn from the case of this 75-year-old active man, a retired engineer, suffering from effort angina CCS 3 for 6 months, referred to the centre by his cardiologist for a coronary CT scan. He is a former smoker, has a...
Knocking mitral regurgitation down to improve outcomes: earlier is better, but better late than never! (Episode 2: the left side)
18 May 2023 – From EuroPCR 2023
Help optimize your patients' prognosis by attending this session! You'll learn how proper patient selection and timely interventions lead to lasting results and how to use the latest real-world registry data to gain insight into the safety and effectiveness of M TEER.
More pulses to take you further across all calcium morphologies
17 May 2023 – From EuroPCR 2023
Discover the latest insights on intravascular lithotripsy (IVL) for treating calcified lesions: explore its mechanism of action, technological advancements, and practical tips for challenging cases, including diffuse lesions, left main bifurcations, and eccentric/calcified nodules. Enhance your expertise in IVL with this concise and informative session!
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis
07 Nov 2021
Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.
Author
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
Transfemoral TAVI in the horizontal aorta
12 May 2020
Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.
